Atorvastatin treatment reduces exercise capacities in rats: Involvement of mitochondrial impairments and oxidative stress

Journal of Applied Physiology

Volumn 111, Issue 5, 2011, Pages 1477-1483

  Bouitbir, Jamal ^a,b   Charles, Anne Laure ^a,b   Rasseneur, Laurence ^a   Dufour, Stéphane ^a   Piquard, François ^a,b   Geny, Bernard ^a,b   Zoll, Joffrey ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Glycogen; Reactive oxygen species; Skeletal muscle

Indexed keywords

ATORVASTATIN; CHOLESTEROL; CREATINE KINASE; GLUCOSE TRANSPORTER 4; GLYCOGEN; HEPTANOIC ACID DERIVATIVE; MESSENGER RNA; PYRROLE DERIVATIVE; REACTIVE OXYGEN METABOLITE; SLC2A4 PROTEIN, RAT;

ANIMAL; ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; BLOOD; CELL RESPIRATION; DRUG EFFECT; ENDURANCE; GENETICS; MALE; METABOLISM; MITOCHONDRION; OXIDATIVE STRESS; PHYSIOLOGY; RAT; SKELETAL MUSCLE; WISTAR RAT;

ANIMALS; CELL RESPIRATION; CHOLESTEROL; CREATINE KINASE; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN; HEPTANOIC ACIDS; MALE; MITOCHONDRIA; MUSCLE, SKELETAL; OXIDATIVE STRESS; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL ENDURANCE; PYRROLES; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RNA, MESSENGER;

EID: 81355150408     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00107.2011     Document Type: Article

References (46)

1. Alegret M, Silvestre JS. Pleiotropic effects of statins and related pharmacological experimental approaches. Methods Find Exp Clin Pharmacol 28: 627-656, 2006. (Pubitemid 46133012)
2. Bao N, Minatoguchi S, Kobayashi H, Yasuda S, Kawamura I, Iwasa M, Yamaki T, Sumi S, Misao Y, Arai M, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H. Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits. Circ J 71: 1622-1628, 2007. (Pubitemid 47529667)
3. Brookes PS. Mitochondrial H(-) leak and ROS generation: an odd couple. Free Radic Biol Med 38: 12-23, 2005. (Pubitemid 39626904)
4. Cheng G, Chunlei W, Pei W, Zhen L, Xiangzhen L. Simvastatin activates Akt/glycogen synthase kinase-3beta signal and inhibits caspase-3 activation after experimental subarachnoid hemorrhage. Vascular Pharmacol 52: 77-83, 2010.
5. Dirks AJ, Jones KM. Statin-induced apoptosis and skeletal myopathy. Am J Physiol Cell Physiol 291: C1208-C1212, 2006. (Pubitemid 44878591)
6. England JD, Walsh JC, Stewart P, Boyd I, Rohan A, Halmagyi GM. Mitochondrial myopathy developing on treatment with the HMG CoA reductase inhibitors-simvastatin and pravastatin. Aust NZ J Med 25: 374-375, 1995.
7. Evans M, Rees A. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same? Drug Saf 25: 649-663, 2002.
8. Fluck M, Hoppeler H. Molecular basis of skeletal muscle plasticity-from gene to form and function. Rev Physiol Biochem Pharmacol 146: 159-216, 2003.
9. Furuya DT, Poletto AC, Favaro RR, Martins JO, Zorn TM, Machado UF. Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice. Metabolism 59: 395-399, 2009.
10. Holmes B, Dohm GL. Regulation of GLUT4 gene expression during exercise. Med Sci Sports Exercise 36: 1202-1206, 2004. (Pubitemid 38878996)
11. Hood DA. Invited Review: Contractile activity-induced mitochondrial biogenesis in skeletal muscle. J Appl Physiol 90: 1137-1157, 2001. (Pubitemid 32171405)
12. Jasinska M, Owczarek J, Orszulak-Michalak D. Statins: a new insight into their mechanisms of action and consequent pleiotropic effects. Pharmacol Rep 59: 483-499, 2007.
13. Kaufmann P, Torok M, Zahno A, Waldhauser KM, Brecht K, Krahenbuhl S. Toxicity of statins on rat skeletal muscle mitochondria. Cell Mol Life Sci 63: 2415-2425, 2006. (Pubitemid 44653050)
14. Krishnan GM, Thompson PD. The effects of statins on skeletal muscle strength and exercise performance. Curr Opin Lipidol 21: 324-328, 2010.
15. Lecarpentier Y. Physiological role of free radicals in skeletal muscles. J Appl Physiol 103: 1917-1918, 2007. (Pubitemid 350232371)
16. Liu W, Saint DA. A new quantitative method of real time reverse transcription polymerase chain reaction assay based on simulation of polymerase chain reaction kinetics. Anal Biochem 302: 52-59, 2002. (Pubitemid 34174608)
17. McArdle A, Pattwell D, Vasilaki A, Griffiths RD, Jackson MJ. Contractile activity-induced oxidative stress: cellular origin and adaptive responses. Am J Physiol Cell Physiol 280: C621-C627, 2001.
18. McGuire TF, Xu XQ, Corey SJ, Romero GG, Sebti SM. Lovastatin disrupts early events in insulin signaling: a potential mechanism of lovastatin's anti-mitogenic activity. Biochem Biophys Res Commun 204: 399-406, 1994.
19. Meador BM, Huey KA. Statin-associated myopathy and its exacerbation with exercise. Muscle Nerve 42: 469-479, 2010.
20. Mettauer B, Zoll J, Sanchez H, Lampert E, Ribera F, Veksler V, Bigard X, Mateo P, Epailly E, Lonsdorfer J, Ventura-Clapier R. Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects. J Am Coll Cardiol 38: 947-954, 2001. (Pubitemid 32912693)
21. Mulsch A, Oelze M, Kloss S, Mollnau H, Topfer A, Smolenski A, Walter U, Stasch JP, Warnholtz A, Hink U, Meinertz T, Munzel T. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Circulation 103: 2188-2194, 2001. (Pubitemid 32463296)
22. Murat JC, Serfaty A. Simple enzymatic determination of polysaccharide (glycogen) content of animal tissues. Clin Chem 20: 1576-1577, 1974.
23. N'Guessan B, Zoll J, Ribera F, Ponsot E, Lampert E, Ventura-Clapier R, Veksler V, Mettauer B. Evaluation of quantitative and qualitative aspects of mitochondrial function in human skeletal and cardiac muscles. Mol Cell Biochem 256-257: 267-280, 2004. (Pubitemid 38181251)
24. Piantadosi CA, Carraway MS, Babiker A, Suliman HB. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res 103: 1232-1240, 2008.
25. Powers SK, Quindry JC, Kavazis AN. Exercise-induced cardioprotection against myocardial ischemia-reperfusion injury. Free Radic Biol Med 44: 193-201, 2008.
26. Qi XF, Kim DH, Yoon YS, Kim SK, Cai DQ, Teng YC, Shim KY, Lee KJ. Involvement of oxidative stress in simvastatin-induced apoptosis of murine CT26 colon carcinoma cells. Toxicol Lett 199: 277-287, 2009.
27. Ramakers C, Ruijter JM, Deprez RH, Moorman AF. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 339: 62-66, 2003. (Pubitemid 36263221)
28. Rayasam GV, Tulasi VK, Sodhi R, Davis JA, Ray A. Glycogen synthase kinase 3: more than a namesake. Br J Pharmacol 156: 885-898, 2009.
29. Robinson MM, Hamilton KL, Miller BF. The interactions of some commonly consumed drugs with mitochondrial adaptations to exercise. J Appl Physiol 107: 8-16, 2009.
30. Sano M, Fukuda K. Activation of mitochondrial biogenesis by hormesis. Circ Res 103: 1191-1193, 2008.
31. Sinzinger H, O'Grady J. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol 57: 525-528, 2004. (Pubitemid 38519660)
32. Sirvent P, Bordenave S, Vermaelen M, Roels B, Vassort G, Mercier J, Raynaud E, Lacampagne A. Simvastatin induces impairment in skeletal muscle while heart is protected. Biochem Biophys Res Commun 338: 1426-1434, 2005. (Pubitemid 41608410)
33. Sirvent P, Mercier J, Lacampagne A. New insights into mechanisms of statin-associated myotoxicity. Curr Opin Pharmacol 8: 333-338, 2008.
34. Sirvent P, Mercier J, Vassort G, Lacampagne A. Simvastatin triggers mitochondria-induced Ca2 signaling alteration in skeletal muscle. Biochem Biophys Res Commun 329: 1067-1075, 2005. (Pubitemid 40341384)
35. Smith PF, Eydelloth RS, Grossman SJ, Stubbs RJ, Schwartz MS, Germershausen JI, Vyas KP, Kari PH, MacDonald JS. HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies. J Pharmacol Exp Therap 257: 1225-1235, 1991.
36. Staffa JA, Chang J, Green L. Cerivastatin and reports of fatal rhabdomyolysis. N Engl J Med 346: 539-540, 2002.
37. Takaguri A, Satoh K, Itagaki M, Tokumitsu Y, Ichihara K. Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes. J Pharm Sci 107: 80-89, 2008. (Pubitemid 351744086)
38. Takemoto M, Node K, Nakagami H, Liao Y, Grimm M, Takemoto Y, Kitakaze M, Liao JK. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 108: 1429-1437, 2001. (Pubitemid 33091980)
39. Thompson PD, Gadaleta PA, Yurgalevitch S, Cullinane E, Herbert PN. Effects of exercise and lovastatin on serum creatine kinase activity. Metabolism 40: 1333-1336, 1991.
40. Thompson PD, Zmuda JM, Domalik LJ, Zimet RJ, Staggers J, Guyton JR. Lovastatin increases exercise-induced skeletal muscle injury. Metabolism 46: 1206-1210, 1997. (Pubitemid 27418513)
41. Thorburn AW, Gumbiner B, Bulacan F, Brechtel G, Henry RR. Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J Clin Invest 87: 489-495, 1991.
42. Tomlinson SS, Mangione KK. Potential adverse effects of statins on muscle. Phys Ther 85: 459-465, 2005. (Pubitemid 40586829)
43. Tonkonogi M, Walsh B, Tiivel T, Saks V, Sahlin K. Mitochondrial function in human skeletal muscle is not impaired by high intensity exercise. Pflügers Arch 437: 562-568, 1999. (Pubitemid 29110908)
44. Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, Moore DD, Auwerx J. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 113: 1408-1418, 2004. (Pubitemid 39071696)
45. Zoll J, N'Guessan B, Ribera F, Lampert E, Fortin D, Veksler V, Bigard X, Geny B, Lonsdorfer J, Ventura-Clapier R, Mettauer B. Preserved response of mitochondrial function to short-term endurance training in skeletal muscle of heart transplant recipients. J Am Coll Cardiol 42: 126-132, 2003. (Pubitemid 36760773)
46. Zoll J, Sanchez H, N'Guessan B, Ribera F, Lampert E, Bigard X, Serrurier B, Fortin D, Geny B, Veksler V, Ventura-Clapier R, Mettauer B. Physical activity changes the regulation of mitochondrial respiration in human skeletal muscle. J Physiol 543: 191-200, 2002. (Pubitemid 34947306)